| 发明名称 |
USE OF URODILATIN FOR PREPARING A MEDICAMENT FOR THE TREATMENT OF CARDIOVASCULAR, RENAL, PULMONARY AND NEURONAL SYNDROMES WHILE AVOIDING A REBOUND |
| 摘要 |
Use of urodilatin for preparing a medicament for the treatment of cardiovascular, renal, pulmonary and neuronal syndromes while avoiding a rebound, wherein said medicament for the delivery of urodilatin is suitable in a first quantity for a first period of at least 48 hours, followed by delivery over a second period of at least 12 hours with successive reduction of said first quantity continuously or gradually to 0 ng/kg/min. |
| 申请公布号 |
US2016303199(A1) |
申请公布日期 |
2016.10.20 |
| 申请号 |
US201514944504 |
申请日期 |
2015.11.18 |
| 申请人 |
CARDIOPEP PHARMA GMBH |
发明人 |
FORSSMANN Wolf-Georg |
| 分类号 |
A61K38/22;A61K47/26 |
主分类号 |
A61K38/22 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. Use of urodilatin for preparing a medicament for the treatment of cardiovascular, renal, pulmonary and neuronal syndromes while avoiding a rebound, wherein said medicament for the delivery of urodilatin is suitable in a first quantity for a first period of 48 hours or more, followed by delivery over a second period of 12 hours or more, in particular 24 hours or more with successive reduction of said first quantity continuously or gradually to 0 ng/kg/min. |
| 地址 |
HANNOVER DE |
